Is telehealth allowed to prescribe Strattera in Pennsylvania?

When seeking treatment for ADHD, many patients wonder if they can receive care and prescriptions through telehealth services. With the rise of virtual healthcare, especially since 2020, the landscape has evolved significantly. This article specifically focuses on non-stimulant ADHD medications like Strattera (atomoxetine) and whether these can be prescribed through telehealth platforms in 2025.

Non-Stimulant ADHD Medications and Telehealth: The Short Answer

Yes, you can get non-stimulant ADHD medications like Strattera through telehealth in all 50 states. Since medications like Strattera are not controlled substances, they aren’t subject to the same strict federal regulations that govern stimulants like Adderall or Ritalin.

A licensed healthcare provider can evaluate you via video telehealth, confirm an ADHD diagnosis, and electronically prescribe Strattera if appropriate for your condition—all without requiring an in-person visit in most cases.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding Non-Stimulant ADHD Medications

Non-stimulant medications offer an alternative approach to ADHD treatment. Unlike their stimulant counterparts, these medications:

• Are not controlled substances
• Don’t carry risk of dependency
• Work differently in the brain
• Often take longer to show full effects (4-6 weeks vs. same-day for stimulants)
• Can be prescribed with fewer regulatory restrictions

Strattera (atomoxetine) is the most commonly prescribed non-stimulant medication for ADHD. As a selective norepinephrine reuptake inhibitor, it works by increasing levels of the neurotransmitter norepinephrine in the brain, which helps improve attention and reduce impulsivity.

Telehealth Prescribing: Federal vs. State Regulations

Federal Regulations

At the federal level, the distinction between stimulant and non-stimulant ADHD medications is crucial:

• Non-stimulants (like Strattera): These medications are not controlled substances, so they’re exempt from DEA restrictions on telehealth prescribing. There’s no federal requirement for an in-person examination before prescribing these medications via telehealth.

• Stimulants (like Adderall): These are Schedule II controlled substances. As of late 2025, the DEA’s COVID-era telehealth flexibilities remain in effect, allowing prescribing without an in-person exam through December 31, 2025. However, this is temporary and subject to change.

State Regulations

While federal law permits telehealth prescribing of non-stimulants, state laws can add additional requirements. The good news is that no state completely prohibits telehealth prescribing of non-stimulant ADHD medications. Some states have specific rules that may affect your telehealth experience:

• California, Texas, Georgia, and Illinois: No special restrictions on telehealth prescribing of non-controlled medications.

• Alabama: Requires a follow-up in-person visit within 12 months for ongoing telehealth treatment, but importantly, this requirement is waived for mental health services, which typically includes ADHD care.

• New Hampshire: Recently updated its laws to allow telehealth prescribing without an initial in-person exam, requiring only an annual evaluation (which can be conducted via telehealth).

• Florida and New York: While these states have stricter rules for telehealth prescribing of controlled substances, non-stimulants like Strattera are exempt from these additional requirements.

Who Can Prescribe Non-Stimulant ADHD Medications via Telehealth?

The type of provider who can prescribe your ADHD medication through telehealth depends on state laws regarding prescribing authority:

• Physicians (MD/DO): In all states, licensed physicians can prescribe non-stimulant ADHD medications via telehealth.

• Nurse Practitioners (NPs): All states allow NPs to prescribe non-controlled drugs like Strattera, though some require a collaborative agreement with a physician:

• Independent practice states (NY, IL, NH, and about 20 others): NPs can prescribe independently

• Collaborative practice states (TX, FL, PA, AL, GA): NPs require some form of physician oversight

• Physician Assistants (PAs): Similar to NPs, PAs can prescribe non-stimulants in all states, typically under physician supervision.

At Klarity Health, we ensure all our providers are properly licensed in your state and authorized to prescribe the medications you may need. Our network includes psychiatrists, psychiatric nurse practitioners, and other mental health professionals specifically trained in ADHD treatment.

What to Expect During a Telehealth ADHD Evaluation

A legitimate telehealth ADHD evaluation should be comprehensive. At Klarity Health, our evaluation process typically includes:

1. Initial Assessment: A thorough review of your symptoms, medical history, and any previous ADHD evaluations or treatments

2. DSM-5 Criteria Evaluation: Using standardized diagnostic criteria to accurately assess ADHD

3. Treatment Planning: Discussion of medication options, including the benefits and potential side effects of stimulant vs. non-stimulant approaches

4. Follow-up Care: Regular check-ins to monitor treatment effectiveness and address any side effects

For non-stimulant medications like Strattera, providers will specifically:

• Screen for contraindications (like narrow-angle glaucoma or recent MAOI use)
• Check for potential drug interactions
• Discuss the expected timeline for seeing benefits (typically 4-6 weeks)
• Monitor for possible side effects, particularly during the initial adjustment period

Benefits of Non-Stimulant Medications via Telehealth

There are several advantages to pursuing non-stimulant ADHD treatment through telehealth:

• Accessibility: Treatment from home, without travel to medical offices
• Fewer Regulatory Hurdles: No controlled substance restrictions
• Convenience in Prescribing: Potential for 90-day supplies and electronic refills
• Good Option for Certain Patients: Particularly beneficial for those with anxiety, substance use concerns, or cardiovascular issues that might complicate stimulant use
• Reduced Stigma: Private treatment in a comfortable environment

At Klarity Health, we find that many patients who haven’t responded well to stimulants or who prefer to avoid controlled medications do very well on non-stimulants like Strattera when properly monitored and supported.

Common Misconceptions About Telehealth ADHD Treatment

Several misconceptions exist about obtaining ADHD medication through telehealth:

Misconception #1: ‘Online ADHD prescriptions are automatic’

Reality: Legitimate telehealth providers conduct thorough evaluations before prescribing any ADHD medication. At Klarity Health, our providers follow the same diagnostic standards as in-person care, and not everyone will qualify for medication.

Misconception #2: ‘Non-stimulants aren’t effective’

Reality: While stimulants are often first-line treatments, non-stimulants like Strattera can be very effective for many patients. They work differently and may take longer to show full benefits, but they provide 24-hour symptom control without the ups and downs sometimes associated with stimulants.

Misconception #3: ‘Telehealth doctors can’t prescribe controlled drugs’

Reality: Under current federal extensions (through 2025), they can prescribe controlled substances, but this is temporary. For non-stimulants, there has never been a federal prohibition on telehealth prescribing.

Misconception #4: ‘If I get a prescription online, local pharmacies won’t fill it’

Reality: Pharmacies regularly fill telehealth prescriptions, especially for non-controlled medications like Strattera. Electronic prescriptions are standard practice and don’t indicate whether your visit was virtual or in-person.

Tips for Successful Telehealth ADHD Treatment

If you’re considering telehealth treatment for ADHD with non-stimulant medications, these tips can help ensure a positive experience:

1. Choose reputable providers like Klarity Health that employ licensed clinicians and follow proper diagnostic protocols

2. Be honest and thorough during your evaluation – the quality of your care depends on the information you provide

3. Follow up regularly – especially with non-stimulants, which require monitoring over several weeks to assess effectiveness

4. Understand how your medication works – non-stimulants like Strattera typically take 4-6 weeks to reach full effectiveness

5. Use medication as prescribed – even though non-stimulants aren’t controlled, they should still be taken exactly as directed

6. Communicate about side effects – especially during the first few weeks, as your body adjusts to the medication

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment